Development of SAR in an aryl ether series of mGlu5 NAMs leading to the identification of tool compound VU0409106 is described in this Letter. VU0409106 is a potent and selective negative allosteric modulator of mGlu5 that binds at the known allosteric binding site and demonstrates good CNS exposure following intraperitoneal dosing in mice. VU0409106 also proved efficacious in a mouse marble burying model of anxiety, an assay known to be sensitive to mGlu5 antagonists as well as clinically efficacious anxiolytics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846293 | PMC |
| http://dx.doi.org/10.1016/j.bmcl.2013.09.001 | DOI Listing |
Publication Analysis
Top Keywords
negative allosteric
8
allosteric modulator
8
modulator mglu5
8
model anxiety
8
discovery vu0409106
4
vu0409106 negative
4
mglu5
4
mglu5 activity
4
activity mouse
4
mouse model
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!